Curat Global LLC Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Curat Global LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 320 shares of the healthcare conglomerate’s stock, valued at approximately $168,000.

A number of other hedge funds have also recently bought and sold shares of the company. Capital & Planning LLC raised its stake in shares of UnitedHealth Group by 19.2% during the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate’s stock worth $248,000 after buying an additional 79 shares during the last quarter. Brighton Jones LLC lifted its stake in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the period. Union Bancaire Privee UBP SA bought a new stake in UnitedHealth Group in the fourth quarter valued at about $27,233,000. Revolve Wealth Partners LLC boosted its holdings in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares during the last quarter. Finally, Silver Oak Securities Incorporated increased its stake in shares of UnitedHealth Group by 24.0% in the 4th quarter. Silver Oak Securities Incorporated now owns 2,878 shares of the healthcare conglomerate’s stock valued at $1,462,000 after acquiring an additional 557 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Barclays lowered their target price on shares of UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a research note on Monday, June 2nd. Hsbc Global Res lowered UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Bank of America cut UnitedHealth Group from a “buy” rating to a “neutral” rating and cut their price objective for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Robert W. Baird dropped their target price on shares of UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating on the stock in a report on Wednesday, May 14th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have given a buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $428.43.

Check Out Our Latest Research Report on UNH

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,533 shares of the company’s stock in a transaction dated Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the stock in a transaction on Friday, May 16th. The shares were bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer now owns 679,493 shares in the company, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is owned by insiders.

UnitedHealth Group Price Performance

NYSE:UNH opened at $303.24 on Friday. The stock has a market capitalization of $275.08 billion, a PE ratio of 19.56, a P/E/G ratio of 1.37 and a beta of 0.44. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a fifty day simple moving average of $409.03 and a 200 day simple moving average of $484.21. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the business posted $6.91 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a $2.21 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 2.92%. The ex-dividend date of this dividend is Monday, June 16th. UnitedHealth Group’s payout ratio is currently 37.02%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.